Harris PC - Search Results

1

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.

Gattone VH 2nd, Wang X, Harris PC, Torres VE. Gattone VH 2nd, et al. Among authors: harris pc. Nat Med. 2003 Oct;9(10):1323-6. doi: 10.1038/nm935. Epub 2003 Sep 21. Nat Med. 2003. PMID: 14502283

2

The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.

Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X, Kubly V, Cunningham JM, Bacallao R, Ishibashi M, Milliner DS, Torres VE, Harris PC. Ward CJ, et al. Among authors: harris pc. Nat Genet. 2002 Mar;30(3):259-69. doi: 10.1038/ng833. Epub 2002 Feb 4. Nat Genet. 2002. PMID: 11919560

3

EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats.

Torres VE, Sweeney WE Jr, Wang X, Qian Q, Harris PC, Frost P, Avner ED. Torres VE, et al. Among authors: harris pc. Kidney Int. 2003 Nov;64(5):1573-9. doi: 10.1046/j.1523-1755.2003.00256.x. Kidney Int. 2003. PMID: 14531789

4

Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease.

Torres VE, Wang X, Qian Q, Somlo S, Harris PC, Gattone VH 2nd. Torres VE, et al. Among authors: harris pc. Nat Med. 2004 Apr;10(4):363-4. doi: 10.1038/nm1004. Epub 2004 Feb 29. Nat Med. 2004. PMID: 14991049

5

Development of multiorgan pathology in the wpk rat model of polycystic kidney disease.

Gattone VH 2nd, Tourkow BA, Trambaugh CM, Yu AC, Whelan S, Phillips CL, Harris PC, Peterson RG. Gattone VH 2nd, et al. Among authors: harris pc. Anat Rec A Discov Mol Cell Evol Biol. 2004 Apr;277(2):384-95. doi: 10.1002/ar.a.20022. Anat Rec A Discov Mol Cell Evol Biol. 2004. PMID: 15052665

6

Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats.

Torres VE, Sweeney WE Jr, Wang X, Qian Q, Harris PC, Frost P, Avner ED. Torres VE, et al. Among authors: harris pc. Kidney Int. 2004 Nov;66(5):1766-73. doi: 10.1111/j.1523-1755.2004.00952.x. Kidney Int. 2004. PMID: 15496147

7

Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.

Wang X, Gattone V 2nd, Harris PC, Torres VE. Wang X, et al. Among authors: harris pc. J Am Soc Nephrol. 2005 Apr;16(4):846-51. doi: 10.1681/ASN.2004121090. Epub 2005 Feb 23. J Am Soc Nephrol. 2005. PMID: 15728778

8

Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD).

Adeva M, El-Youssef M, Rossetti S, Kamath PS, Kubly V, Consugar MB, Milliner DM, King BF, Torres VE, Harris PC. Adeva M, et al. Among authors: harris pc. Medicine (Baltimore). 2006 Jan;85(1):1-21. doi: 10.1097/01.md.0000200165.90373.9a. Medicine (Baltimore). 2006. PMID: 16523049

9

Volume progression in polycystic kidney disease.

Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP; CRISP Investigators. Grantham JJ, et al. Among authors: harris pc. N Engl J Med. 2006 May 18;354(20):2122-30. doi: 10.1056/NEJMoa054341. N Engl J Med. 2006. PMID: 16707749

10

Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases.

Torres VE, Harris PC. Torres VE, et al. Among authors: harris pc. Nat Clin Pract Nephrol. 2006 Jan;2(1):40-55; quiz 55. doi: 10.1038/ncpneph0070. Nat Clin Pract Nephrol. 2006. PMID: 16932388 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results